The molecular pathology of central neurocytomas

[1]  Eric C. Holland,et al.  Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma , 2010, Nature Reviews Cancer.

[2]  Kevin J. Wu,et al.  Interphase Cytogenetics for 1p19q and t(1;19)(q10;p10) may Distinguish Prognostically Relevant Subgroups in Extraventricular Neurocytoma , 2009, Brain pathology.

[3]  Borivoj Vojtesek,et al.  Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment , 2008, Journal of cellular and molecular medicine.

[4]  H. Kettenmann,et al.  Human central neurocytoma cells show neuronal physiological properties in vitro , 2009, Acta Neuropathologica.

[5]  J. Shinoda,et al.  Immunohistochemical Study Concerning the Origin of Neurocytoma—A Case Report , 2009, Pathology and Oncology Research.

[6]  V. Rohde,et al.  Nogo-A Expression in Glial CNS Tumors: A Tool to Differentiate Between Oligodendrogliomas and Other Gliomas? , 2008, The American journal of surgical pathology.

[7]  S. G. Malakho,et al.  Fast detection of MYCN copy number alterations in brain neuronal tumors by real‐time PCR , 2008, Journal of clinical laboratory analysis.

[8]  M. Scott,et al.  Insulin-like Growth Factor 2 Is Required for Progression to Advanced Medulloblastoma in patched 1 Heterozygous Mice , 2008 .

[9]  F. Révillion,et al.  ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  H. Arai,et al.  Ganglioneurocytoma: Distinctive variant of central neurocytoma , 2007, Pathology international.

[11]  B. Scheithauer,et al.  Central neurocytoma: management recommendations based on a 35-year experience. , 2007, International journal of radiation oncology, biology, physics.

[12]  Zora Modrusan,et al.  Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma , 2007, Proceedings of the National Academy of Sciences.

[13]  J. Greenfield,et al.  Neurocytoma Is a Tumor of Adult Neuronal Progenitor Cells , 2007 .

[14]  F. Henderson,et al.  Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor , 2007, Journal of Neuro-Oncology.

[15]  A. Korshunov,et al.  Recurrent cytogenetic aberrations in central neurocytomas and their biological relevance , 2007, Acta Neuropathologica.

[16]  J. Bottenstein,et al.  Neuregulin 1 growth factors regulate proliferation but not apoptosis of a CNS neuronal progenitor cell line , 2006, Brain Research.

[17]  R. Delfini,et al.  Central neurocytoma: a novel appraisal of a polymorphic pathology Our experience and a review of the literature , 2006, Neurosurgical Review.

[18]  H. Heinzl,et al.  Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology , 2006, Histopathology.

[19]  H. T. Ghashghaei,et al.  The role of neuregulin-ErbB4 interactions on the proliferation and organization of cells in the subventricular zone. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Deimling,et al.  45‐ YEAR‐OLD MALE WITH SYMPTOMATIC MASS IN THE FRONTAL LOBE , 2006, Brain pathology.

[21]  M. Mut,et al.  Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma. , 2005, Clinical neuropathology.

[22]  D. Prayer,et al.  Recurrent central neurocytomas , 2005, Cancer.

[23]  A. Pession,et al.  The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors. , 2005, Current cancer drug targets.

[24]  U. Schüller,et al.  Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. , 2005, The American journal of pathology.

[25]  B. Feuerstein,et al.  Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas , 2005, Genes, chromosomes & cancer.

[26]  D. Taruscio,et al.  Nonrandom gain of chromosome 7 in central neurocytoma: A chromosomal analysis and fluorescence in situ hybridization study , 2005, Virchows Archiv.

[27]  S. Paek,et al.  Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma , 2005, Journal of Neuro-Oncology.

[28]  K. Park,et al.  Cerebral neurocytoma without ganglion cell differentiation , 2005, Acta Neurochirurgica.

[29]  N. Boddaert,et al.  Fourth ventricle neurocytoma with lipomatous and ependymal differentiation , 2005, Acta Neuropathologica.

[30]  H. Okano,et al.  Possible Oncogenicity of Subventricular Zone Neural Stem Cells: Case Report , 2004, Neurosurgery.

[31]  D. Louis,et al.  Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss. , 2004, Human pathology.

[32]  G. Rao,et al.  Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice , 2004, Oncogene.

[33]  D. Pfaff,et al.  Inhibition of neuronal phenotype by PTEN in PC12 cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Paek,et al.  Forskolin promotes astroglial differentiation of human central neurocytoma cells , 2004, Experimental & Molecular Medicine.

[35]  Mitchel S. Berger,et al.  Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration , 2004, Nature.

[36]  A. Asai,et al.  Proliferative activity of central neurocytoma: Measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index , 1997, Journal of Neuro-Oncology.

[37]  K. Zang,et al.  Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines , 1986, Human Genetics.

[38]  S. Tsunoda,et al.  Central neurocytoma: immunohistochemical and ultrastructural study , 2004, Acta Neuropathologica.

[39]  G. Salamon,et al.  Central neurocytoma , 2004, Acta Neuropathologica.

[40]  Y. Sugisaki,et al.  Central neurocytoma expressing characteristics of ependymal differentiation: electron microscopic findings of two cases , 2003, Medical Electron Microscopy.

[41]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[42]  A. Hoffman,et al.  A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. , 2003, The Journal of clinical investigation.

[43]  D. Brat,et al.  Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. , 2003, Frontiers in bioscience : a journal and virtual library.

[44]  M. Berker,et al.  Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma. , 2003, Pathology, research and practice.

[45]  Juthamas Sukbuntherng,et al.  In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  O. Tachibana,et al.  Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors. , 2002, Journal of neurosurgery.

[47]  D. Rades,et al.  Treatment options for central neurocytoma , 2002, Neurology.

[48]  R. Eisenman,et al.  N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. , 2002, Genes & development.

[49]  L. Parada,et al.  The Molecular and Genetic Basis of Neurological Tumours , 2002, Nature Reviews Cancer.

[50]  M. Israel,et al.  Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. , 2002, Cancer research.

[51]  M. Jeffers,et al.  Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer. , 2002, Cancer research.

[52]  M. Shigemori,et al.  The biochemical analysis of neurotransmitters in central neurocytomas. , 2001, International journal of molecular medicine.

[53]  Arturo Alvarez-Buylla,et al.  A unified hypothesis on the lineage of neural stem cells , 2001, Nature Reviews Neuroscience.

[54]  S. Ogino,et al.  Comparative Immunohistochemical Study of Insulin-like Growth Factor II and Insulin-like Growth Factor ReceptorType 1 in Pediatric Brain Tumors , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[55]  J. Pang,et al.  Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas , 2000, Histopathology.

[56]  A. Hui,et al.  Detection of chromosomal imbalances in central neurocytomas by using comparative genomic hybridization. , 2000, Journal of neurosurgery.

[57]  D. Louis,et al.  Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. , 2000, Journal of neurosurgery.

[58]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  Daniel A. Lim,et al.  Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain , 1999, Cell.

[60]  I. Mackenzie.  Central neurocytoma , 1999, Cancer.

[61]  V. Jay,et al.  Central neurocytoma: morphological, flow cytometric, polymerase chain reaction, fluorescence in situ hybridization, and karyotypic analyses. Case report. , 1999, Journal of neurosurgery.

[62]  Jonas Frisén,et al.  Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System , 1999, Cell.

[63]  M. Westphal,et al.  Tissue culture of human neurocytomas induces the expression of glial fibrilary acidic protein , 1998, Journal of neurocytology.

[64]  W. Marston Linehan,et al.  Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas , 1998, Nature Genetics.

[65]  Ian N. M. Day,et al.  Molecules in focus Insulin-like growth factor II (IGF-II) , 1998 .

[66]  M. Tamura,et al.  In vitro neuronal and glial production and differentiation of human central neurocytoma cells , 1998, Journal of neuroscience research.

[67]  石内勝吾.  Central neurocytoma: an immunohistochemical,ultrastructural and cell culture study(神経細胞腫の免疫組織化学的,電子顕微鏡学的及び組織培養学的研究) , 1998 .

[68]  I. Day,et al.  Insulin-like growth factor II (IGF-II). , 1998, The international journal of biochemistry & cell biology.

[69]  K. Kawamoto,et al.  Ultrastructural characterization of central neurocytomas using collagen gel culture. , 1998, Ultrastructural pathology.

[70]  D. Louis,et al.  Chemosensitive gliomas in adults: which ones and why? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  J. Weber,et al.  Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases , 1997, Nature.

[72]  B. Scheithauer,et al.  Atypical Central Neurocytoma , 1997, Journal of neuropathology and experimental neurology.

[73]  K. Kawamoto,et al.  Neuronal and glial characteristics of central neurocytoma: electron microscopical analysis of two cases , 1996, Acta Neuropathologica.

[74]  M. Weller,et al.  Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. , 1995, The Journal of clinical investigation.

[75]  M. Westphal,et al.  Human neurocytoma cells in culture show characteristics of astroglial differentiation , 1994, Journal of neuroscience research.

[76]  B. Wullich,et al.  Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. , 1994, Anticancer research.

[77]  Iver Petersen,et al.  Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system , 1993, Molecular carcinogenesis.

[78]  S. Vandenberg,et al.  Cytoskeletal Immunohistochemistry of Central Neurocytomas , 1992, The American journal of surgical pathology.

[79]  C. Daumas-Duport,et al.  Central Neurocytomas: Critical Evaluation of a Small‐Cell Neuronal Tumor , 1992 .

[80]  T. Südhof,et al.  Histogenesis and differentiation potential of central neurocytomas. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[81]  R. Janzer,et al.  Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. , 1990, Acta neuropathologica.

[82]  L. J. Rubinstein,et al.  Tumors of the central nervous system , 1972 .